Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_assertion type Assertion NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_head.
- NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_assertion description "[We also show that differential EphA2 expression and function may provide a unique opportunity for selective therapeutic targeting of EphA2 in metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_provenance.
- NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_assertion evidence source_evidence_literature NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_provenance.
- NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_assertion SIO_000772 12650608 NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_provenance.
- NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_assertion wasDerivedFrom befree-20140225 NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_provenance.
- NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_assertion wasGeneratedBy ECO_0000203 NP475629.RAChUyRxXhuYTwUsBZkZpNVNGZ6bx38isF4mV91h-SZ1I130_provenance.